Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: administration of drug ivermectin for patients of mild or moderate COVID and assess response on virological clearance: administration of drug ivermectin for patients of mild or moderate COVID and assess response on virological clearance . The drug will be administered as a single dose at dose of 0.2 mg/kg as per institutional protocols. It will not be repeated.Control Intervention1: no ivermectin administration ; rest all patients; will receive treatment as per departmental protocol; which may include; vitamin C; Zinc; antipyretic; ranitidine/omeprazole/chloroquine ; azithromycin etc. The only exception is the use of ivermectin; which will be used in the study group and not in the control group: no ivermectin administration ; rest all patients; will receive treatment as per departmental protocol; which may include; vitamin C; Zinc; antipyretic; ranitidine/omeprazole/chloroquine ; azithromycin etc. The only exception is the use of ivermectin; which will be used in the study group and not in the control group", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: administration of drug ivermectin for patients of mild or moderate COVID and assess response on virological clearance: administration of drug ivermectin for patients of mild or moderate COVID and assess response on virological clearance . The drug will be administered as a single dose at dose of 0.2 mg/kg as per institutional protocols. It will not be repeated.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: no ivermectin administration ; rest all patients; will receive treatment as per departmental protocol; which may include; vitamin C; Zinc; antipyretic; ranitidine/omeprazole/chloroquine ; azithromycin etc. The only exception is the use of ivermectin; which will be used in the study group and not in the control group: no ivermectin administration ; rest all patients; will receive treatment as per departmental protocol; which may include; vitamin C; Zinc; antipyretic; ranitidine/omeprazole/chloroquine ; azithromycin etc. The only exception is the use of ivermectin; which will be used in the study group and not in the control group", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

Nov. 13, 2021, 5:33 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

Oct. 26, 2020, 8:29 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: administration of drug ivermectin for patients of mild or moderate COVID and assess response on virological clearance: administration of drug ivermectin for patients of mild or moderate COVID and assess response on virological clearance . The drug will be administered as a single dose at dose of 0.2 mg/kg as per institutional protocols. It will not be repeated.Control Intervention1: no ivermectin administration ; rest all patients; will receive treatment as per departmental protocol; which may include; vitamin C; Zinc; antipyretic; ranitidine/omeprazole/chloroquine ; azithromycin etc. The only exception is the use of ivermectin; which will be used in the study group and not in the control group: no ivermectin administration ; rest all patients; will receive treatment as per departmental protocol; which may include; vitamin C; Zinc; antipyretic; ranitidine/omeprazole/chloroquine ; azithromycin etc. The only exception is the use of ivermectin; which will be used in the study group and not in the control group", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: administration of drug ivermectin for patients of mild or moderate COVID and assess response on virological clearance: administration of drug ivermectin for patients of mild or moderate COVID and assess response on virological clearance . The drug will be administered as a single dose at dose of 0.2 mg/kg as per institutional protocols. It will not be repeated.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: no ivermectin administration ; rest all patients; will receive treatment as per departmental protocol; which may include; vitamin C; Zinc; antipyretic; ranitidine/omeprazole/chloroquine ; azithromycin etc. The only exception is the use of ivermectin; which will be used in the study group and not in the control group: no ivermectin administration ; rest all patients; will receive treatment as per departmental protocol; which may include; vitamin C; Zinc; antipyretic; ranitidine/omeprazole/chloroquine ; azithromycin etc. The only exception is the use of ivermectin; which will be used in the study group and not in the control group", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]